SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
TRUEX PAUL F

(Last) (First) (Middle)
25801 INDUSTRIAL BLVD SUITE B

(Street)
HAYWARD CA 94545

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Anthera Pharmaceuticals Inc [ ANTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/27/2014
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/25/2014 F 7,622(1) D $3.3(2) 9,333(3) D
Common Stock 03/25/2014 A 3,864(4) A (5) 13,197(3) D
Common Stock 03/25/2014 F 1,352(1) D $3.3(2) 11,845(3) D
Common Stock 06/30/2013 A 6,250(6) A $3.3 80,190(3)(7) I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy $3.3 03/25/2014 A 18,440(8) 03/25/2014 03/25/2024 Common Stock 18,440 $0 18,440 D
Explanation of Responses:
1. Shares forfeited in lieu of payment of tax liability in connection with the vesting of 16,956 performance shares and 3,864 performance shares which represent the portion of the Reporting Person?s 2012 and 2013 performance share awards.
2. The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer?s common stock on March 25, 2014, the vesting date of the 2012 and 2013 Grants.
3. Shares have been adjusted to reflect the Issuer?s 1-for -8 reverse stock split effectuated July 15, 2013.
4. Award of Restricted Stock Units under the Issuer?s 2013 Stock Option and Incentive Plan that vest immediately on March 25, 2014.
5. Not applicable.
6. Shares acquired under the Issuer?s 2010 Employee Stock Purchase Plan on June 30 2013.
7. This amended Form 4 is being filed for the purpose of correcting an incorrect Form 4 filed on March 27, 2014 reflecting ownership numbers that were pre-split. This corrects the numbers to reflect the Issuer?s 1-8-reverse split effectuated July 15, 2013.
8. The Stock Option vests immediately on March 25, 2014.
Remarks:
/s/ Paul Truex 03/28/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.